Brupharm Pharmalab(SRL)

BE 0785.641.404

	2022
Profit/Loss Section 9904: Profit/Loss of the financial year (after taxes on result) (+/-)	€ -55.101
Turnover Section 70: Turnover of the financial year	€ 58.722
Equity Section 10/15: Equity consists of capital, capital reserves and earnings that remain within the company. These are fully owned by the company and are at its disposal to cover its risks. The better the ratio between equity and debts, the more solvent a company is. A positive equity ratio is important. A negative equity ratio (because of accumulated losses) is a severe warning sign that the continuity of the company may be threatened.	€ 44.899
Gross margin Section 9900: Gross margin or added value is net sales minus the direct costs of the goods sold. In other words: sales invoices minus purchase invoices (70/74 – 60/61). A negative gross margin is a warning sign especially when occurring over several years. It may indicate that the company has insufficient means to cover internal costs like salaries, etc.	€ -13.622

	Date	Publication
	05-05-2022	Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

What is the VAT number of Brupharm Pharmalab?

The VAT number of Brupharm Pharmalab is BE0785641404.

When was Brupharm Pharmalab founded?

Brupharm Pharmalab was founded on 03-05-2022.

What is the address of Brupharm Pharmalab?

The current registered office of Brupharm Pharmalab is located at Route de Wallonie (G.) 140, 7011 Mons.

When was the last time Brupharm Pharmalab filed their annual financial statements?

The most recent financial statements of Brupharm Pharmalab were filed on 19-04-2024. You can view them here.

How many employees does Brupharm Pharmalab have?

There are currently no employees working at Brupharm Pharmalab or no workforce information is available.

What is the annual turnover of Brupharm Pharmalab?

At the time of its most recent financial statements, Brupharm Pharmalab recorded a total turnover of €58,722.27.